Conquering Diseases

Study Of An Investigational Drug To Improve Surgical Treatment Of Colorectal Cancer

Description

Seeking men and women aged 18 and older whose colon, peritoneal, or rectal cancer will be treated with surgery (resectable) for a study of an investigational drug to make the cancer cells glow under infrared light.

Overview

We are studying if the investigational drug improves the precision of surgery to remove cancer and whether the investigational drug is safe and well tolerated by the people who take it. Some participants will get the investigational drug and some patients will get a placebo (looks like the investigational drug but doesn't contain any medicine) before undergoing surgery.

What we're hoping for

Evaluate whether the investigational drug to make cancer cells glow under infrared light allow surgeons to better identify cancer tumor from healthy tissue to improve the precision of surgical treatment for colon, rectal, or peritoneal cancer.

Additional Information

ClinicalTrials.gov Identifier: NCT03659448

 Principal Investigator

Karim  Alavi, MD, MPH

UMass Memorial Health Care

 Study Contact

Sharon  Balcom

sharon.balcom@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989